ASR Vermogensbeheer’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Buy
59,650
+27,780
+87% +$2.62M 0.04% 290
2026
Q1
$3.77M Buy
31,870
+918
+3% +$114K 0.04% 284
2025
Q4
$3.89M Sell
30,952
-209
-0.7% -$27.3K 0.05% 286
2025
Q3
$4.56M Buy
31,161
+16
+0.1% +$2.42K 0.06% 270
2025
Q2
$4.86M Buy
31,145
+109
+0.4% +$17.3K 0.06% 263
2025
Q1
$5.11M Buy
+31,036
New +$5.16M 0.08% 225

Other funds holding ZTS

ASR Vermogensbeheer's ZTS Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Zoetis (ZTS) stake by 87% in Q2 2026, buying an estimated $2.62M and bringing the position to 59,650 shares worth $4.29M. The position accounts for 0.04% of the portfolio, ranked #290.

ASR Vermogensbeheer first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.11M in Q1 2025. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • ASR Vermogensbeheer held 59,650 shares of Zoetis worth $4.29M as of Q2 2026.
  • ASR Vermogensbeheer bought 27,780 Zoetis shares in Q2 2026, an estimated $2.62M.
  • Zoetis made up 0.04% of ASR Vermogensbeheer's portfolio in Q2 2026, its #290 holding.
  • ASR Vermogensbeheer first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Zoetis position peaked at $5.11M in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.